36262501|t|A Rare Case of Pembrolizumab Associated Encephalopathy.
36262501|a|We present a unique case of a 55-year-old man with confusion thought to be due to pembrolizumab which he was receiving for renal cell carcinoma. His workup for other possible etiologies for encephalopathy was negative. He was treated with high dose intravenous methylprednisolone followed by prednisone taper and intravenous immunoglobulin with gradual improvement in his mentation.
36262501	15	28	Pembrolizumab	Chemical	MESH:C582435
36262501	40	54	Encephalopathy	Disease	MESH:D001927
36262501	98	101	man	Species	
36262501	138	151	pembrolizumab	Chemical	MESH:C582435
36262501	179	199	renal cell carcinoma	Disease	MESH:D002292
36262501	246	260	encephalopathy	Disease	MESH:D001927
36262501	317	335	methylprednisolone	Chemical	MESH:D008775
36262501	348	358	prednisone	Chemical	MESH:D011241
36262501	Negative_Correlation	MESH:D011241	MESH:D002292
36262501	Negative_Correlation	MESH:D008775	MESH:D001927
36262501	Negative_Correlation	MESH:C582435	MESH:D002292
36262501	Negative_Correlation	MESH:D011241	MESH:D001927
36262501	Positive_Correlation	MESH:C582435	MESH:D001927
36262501	Negative_Correlation	MESH:D008775	MESH:D002292

